NCT02188771View on ClinicalTrials.gov

A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Osteoarthritis
Interventions
DEVICE

intra-articular administration of RegenoGel-SP or hyaluronic acid (HA)

Intra-articular Injection: single injection of RegenoGel SP or 3 injections of HA

Trial Locations (1)

Unknown

Assaf Harofe Medical Center, Zrifin

All Listed Sponsors
lead

ProCore Ltd.

INDUSTRY

NCT02188771 - A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis | Biotech Hunter | Biotech Hunter